However, the fusion protein PML-RARα in APL has been suggested to compete with endogenous RARα for binding at the same RA response elements (RAREs), which in turn leads to repression of normal RARα signaling in a dominant-negative manner [7]. This evidence concerns the gene PML and acute promyelocytic leukemia.